ATE245655T1 - Organische-arsenverbindungen - Google Patents

Organische-arsenverbindungen

Info

Publication number
ATE245655T1
ATE245655T1 AT00919444T AT00919444T ATE245655T1 AT E245655 T1 ATE245655 T1 AT E245655T1 AT 00919444 T AT00919444 T AT 00919444T AT 00919444 T AT00919444 T AT 00919444T AT E245655 T1 ATE245655 T1 AT E245655T1
Authority
AT
Austria
Prior art keywords
arsenic compounds
organic arsenic
cancer cells
cells
regard
Prior art date
Application number
AT00919444T
Other languages
English (en)
Inventor
Fatih M Uckun
Xing-Ping Liu
Original Assignee
Parker Hughes Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parker Hughes Inst filed Critical Parker Hughes Inst
Application granted granted Critical
Publication of ATE245655T1 publication Critical patent/ATE245655T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/66—Arsenic compounds
    • C07F9/70—Organo-arsenic compounds
    • C07F9/80—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00919444T 1999-03-19 2000-03-16 Organische-arsenverbindungen ATE245655T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12533799P 1999-03-19 1999-03-19
US09/338,680 US6191123B1 (en) 1999-03-19 1999-06-23 Organic-arsenic compounds
PCT/US2000/007063 WO2000056742A1 (en) 1999-03-19 2000-03-16 Organic-arsenic compounds

Publications (1)

Publication Number Publication Date
ATE245655T1 true ATE245655T1 (de) 2003-08-15

Family

ID=26823484

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00919444T ATE245655T1 (de) 1999-03-19 2000-03-16 Organische-arsenverbindungen

Country Status (8)

Country Link
US (3) US6191123B1 (de)
EP (1) EP1163246B1 (de)
JP (1) JP2002540114A (de)
AT (1) ATE245655T1 (de)
AU (1) AU4013400A (de)
CA (1) CA2365201A1 (de)
DE (1) DE60004027T2 (de)
WO (1) WO2000056742A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191123B1 (en) * 1999-03-19 2001-02-20 Parker Hughes Institute Organic-arsenic compounds
AUPQ296799A0 (en) 1999-09-20 1999-10-14 Unisearch Limited A cell-membrane impermeable trivalent organoarsenical derivative and use thereof
AUPR379801A0 (en) 2001-03-19 2001-04-12 Unisearch Limited Use of a substantially cell membrane impermeable compound for treating arthritis
AUPR874601A0 (en) * 2001-11-08 2001-11-29 Unisearch Limited Selective targeting of apoptotic cells
GB0128405D0 (en) * 2001-11-27 2002-01-16 Btg Int Ltd Process for fabricating polyolefin sheet
US20030135041A1 (en) * 2002-01-04 2003-07-17 Orchid Chemicals & Pharmaceuticals Limited, India Synthesis of ceftiofur intermediate
US6911471B2 (en) 2002-01-07 2005-06-28 The Texas A&M University System S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer
US8394422B2 (en) * 2002-04-26 2013-03-12 Centre National De La Recherche Scientifique (Cnrs) Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans
FR2838965B1 (fr) 2002-04-26 2004-06-25 Centre Nat Rech Scient Therapie par l'arsenic du syndrome autoimmunlymphoproliferatif de type apls chez la souris comme chez l'homme
EP1563099B1 (de) 2002-11-07 2009-07-22 Newsouth Innovations Pty Limited Induktion der mitochondrialen permeabilitätstransition
US6686344B1 (en) * 2003-01-30 2004-02-03 Paker Hughes Institute Organic-arsonic compounds
TW201440760A (zh) * 2004-07-16 2014-11-01 Texas A & M Univ Sys 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物
ES2532666T3 (es) 2005-07-29 2015-03-30 Solasia Pharma K.K. Compuestos y métodos para el tratamiento del cáncer
TW200829261A (en) * 2006-09-29 2008-07-16 Ziopharm Oncology Inc Method for controlling angiogenesis in animals
CN101595115B (zh) 2006-11-01 2012-07-18 新南部创新有限公司 有机-氧化砷化合物及其用途
ES2392737T3 (es) * 2007-11-02 2012-12-13 Ziopharm Oncology, Inc. Terapia combinada con compuestos arsenicales orgánicos
CA2705467A1 (en) * 2007-12-12 2009-06-18 Ziopharm Oncology, Inc. Compounds and methods for the treatment of cancer
RU2534606C2 (ru) 2008-08-20 2014-11-27 Зайофарм Онколоджи, Инк. Мышьякорганические соединения и способы лечения рака
CN102325755B (zh) 2008-12-30 2015-07-01 艾科尔公司 取代的5,6-二氢-6-苯基苯并[f]异喹啉-2-胺化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3017380A (en) * 1958-12-05 1962-01-16 Dal Mon Research Co Aldehyde-triazinyl arsenic condensation products and method of making same
SU977461A1 (ru) * 1981-04-28 1982-11-30 Ордена Ленина Институт Геохимии И Аналитической Химии Им.В.И.Вернадского Способ получени 2,7-бис-(2-арсонофенилазо)-1,8-диоксинафталин-3,6-дисульфокислоты (арсеназо ш)
FR2640269B1 (fr) * 1988-12-13 1991-03-15 Maes Ludo Composes organometalliques, leurs modes de preparation et compositions pharmaceutiques les contenant
FR2684382B1 (fr) * 1991-12-02 1994-10-21 Rhone Merieux Medicaments et preparations pures de dichlorhydrate de melarsomine, leur procede d'obtention et produits intermediaires obtenus.
DE69529575T2 (de) * 1994-11-30 2003-08-21 Univ Hospital Boston Arzneimittel zur behandlung von parasitischen und pilzartigen infektionen
US6191123B1 (en) * 1999-03-19 2001-02-20 Parker Hughes Institute Organic-arsenic compounds

Also Published As

Publication number Publication date
EP1163246A1 (de) 2001-12-19
US6482816B1 (en) 2002-11-19
AU4013400A (en) 2000-10-09
CA2365201A1 (en) 2000-09-28
JP2002540114A (ja) 2002-11-26
WO2000056742A9 (en) 2001-11-01
WO2000056742A1 (en) 2000-09-28
US6191123B1 (en) 2001-02-20
US6482815B1 (en) 2002-11-19
EP1163246B1 (de) 2003-07-23
DE60004027D1 (de) 2003-08-28
DE60004027T2 (de) 2004-04-22

Similar Documents

Publication Publication Date Title
ATE245655T1 (de) Organische-arsenverbindungen
TW200616615A (en) Compounds and methods for the treatment of cancer
YU52099A (sh) Fungicidni trifluormetilalkilamino-triazolpirimidini
PT1318992E (pt) Derivados do imidazole como inibidores da cinase raf
ECSP055863A (es) Piridodiacinas como funguicidas de plantas
GT199900070A (es) Derivados de isotiazol, utiles como agentes anticancerosos.
BR0210471A (pt) Ligandos do receptor 5-ht e suas utilizações
DK1200412T3 (da) Antiproliferative imidazolforbindelser
ECSP066549A (es) Compuestos de pirazolilo e imidazolilo bicíclicos y usos de los mismos
GB0119249D0 (en) Organic compounds
AR022860A1 (es) Derivados de camptotecina que poseen actividad antitumoral
WO2007027344A3 (en) Compounds and methods for the treatment of cancer
HK1040983A1 (en) Quinones for treatment of diseases.
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
EP1643984A4 (de) Verwendung von parthenolid-derivaten als antileukämische und zytotoxische mittel
ATE299505T1 (de) Fungizide 6-(2-halo-4-alkoxyphenyl)- triazolopyrimidine
ATE327973T1 (de) Polyamin-analoge als cytotoxische wirkstoffe
DE602005027739D1 (de) Arylsubstituiertes benzimidazol- und imidazopyridinether als wirkstoffe gegen krebs
DE60100855D1 (de) 1,8-naphthalimid imidazo[4,5,1-de]acridone mit antitumorwirkung
ES2159488B1 (es) Procedimiento para la preparacion de derivados de pirimidona con actividad antifungica.
BRPI0507811A (pt) derivados de 7h-pirrolopirimidina
DK1142905T3 (da) Hidtil ukendt depsipeptidforbindelse
AR021694A1 (es) Retinamidas de acido 7-aril-6-(z)heptatrienoico
AR023979A1 (es) Procesos para preparar compuestos intermedios de plaguicidas
BRPI0417513A (pt) agentes combinados de chp-gemcitabina e seu uso como substáncias antitumorais ativas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties